(Date:11/30/2009)..., LONDON, November 30 ApaTech,...amed Europe,s fastest growing,Biotech/Pharmaceutic...oitte,2009 Technology Fast 500 for EMEA (Europe, M...king is based on a companies, five-year revenue gr...18% over this period. This,achievement places ApaT...
(Date:11/29/2009)...available in German . , The concept of conf...ics. The most famous example is that of quarks whi... Prof. Bella Lake from Helmholtz-Zentrum Berlin to...port for the first time an experimental realizatio...n a condensed matter system. , The concept of co...
(Date:11/27/2009)...URHAM, N.C., Nov. 27 Cromoz Inc., ...ater-soluble carbon nanotube-based cancer drug del...e carbon nanotubes, which have functional groups o...r drugs, was developed in partnership with the Ind...on nanotubes serves as a drug delivery vehicle wit...
(Date:11/27/2009)... A mechanised blue dye test alternative is...ality assurance one step closer for pharma-compani...ting machine developed by Sepha for use with bl...everal local and global pharma-companies such as S...assurance and productivity improvements on the pac...
Breaking Biology Technology:ApaTech is Europe's Fastest Growing Lifescience Company 2ApaTech is Europe's Fastest Growing Lifescience Company 3ApaTech is Europe's Fastest Growing Lifescience Company 4Spinons -- confined like quarks 2North Carolina Based Cromoz Inc. Launches Carbon Nanotechnology for Target Drug Delivery System in Cancer Treatment in Hyderabad, India 2Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance 2Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance 3(Date:11/30/2009)...ov. 30 Reportlinker.com announces ...its catalogue: ,, Outsourcing Opportunities in...ww.reportlinker.com/p0165747/Outsourcing-Opportuni...cription ,, Medical devices form one of the lar...ated size of $250 billion in 2009 and a growth rat...
(Date:11/30/2009)...Nov. 30 StemCyte, Inc. concluded a...t with Academia Sinica, the National Laboratory of...lectual Property (IP) related to the treatment of ...P was pioneered by a team led by Professor John Li...sor Lin is currently the exclusive collaborator wi...
(Date:11/30/2009)...Pa., Nov. 30 Cytokine PharmaScienc... I study of CPSI-2364, its orally active, small-mo...d other pro-inflammatory cytokines. Results of th... healthy volunteers confirm the safety of this com...enrolled subjects completed the study, including t...
Breaking Medicine Technology:Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 2Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 3Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 4Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 5Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 6Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 7Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 8Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 9StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke 2StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke 3Cytokine PharmaSciences Completes Phase I Study of Oral Anti-Inflammatory Agent, CPSI-2364 2Lead in bone associated with increased risk of death from cardiovascular disease in men 56585 1Lead in bone associated with increased risk of death from cardiovascular disease in men 56585 2Baby boomers boon 3F LED light and green tea cream to smooth facial wrinkles 9842 1Toward a nanomedicine for brain cancer 9839 1